ViaGenetics is in the early stages of five additional projects:

 

  • Clinical trial for NURR1 agonist in patients with Parkinson's disease
  • Early stage p.o.c. for high-speed synthetic vaccine production
  • Disease management using cannabinoid receptors and mitochondria
  • Charcot-Marie-Tooth disease research related to degenerative diseases
  • Cellular Switching Mechanisms for Disease Prevention and Anti-Aging

 

ViaGenetics Development Pipeline

ViaGenetics innovative methods, insights and discoveries have created a robust pipeline of

research projects and intellectual property.

© 2017 ViaGenetics. All Rights Reserved.

(305) 865-7000

5244 North Bay Road, Miami Beach, FL 33140